Materias dentro de su búsqueda.
Mostrando 1,841 - 1,860 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.45s Limitar resultados
  1. 1841
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Updated Operational Guidance for Implementing CDC’s Recommendations on Testing for Hepatitis C Virus Infection
  2. 1842
    “…BACKGROUND: Virus infections are presently seen as a major public health problem. Hepatitis C Virus (HCV) is recognized as a “silent killer” because the acute infection has no symptoms, and it develops as a chronic infection that causes hepatocellular carcinoma and liver damage. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Promising alkaloids and flavonoids compounds as anti-hepatitis c virus agents: a review
  3. 1843
    “…Although most of the early events of the hepatitis C virus (HCV) life cycle are well characterized, our understanding of HCV egress is still unclear. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Early Secretory Pathway Is Crucial for Multiple Aspects of the Hepatitis C Virus Life Cycle
  4. 1844
    “…In this study, expression of cellular RRMs, including RRM1 and RRM2, is found to be down-regulated in hepatitis C virus (HCV)-infected Huh7.5 cells and Huh7 cells with HCV subgenomic RNAs (HCVr). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C Virus Down-Regulates the Expression of Ribonucleotide Reductases to Promote Its Replication
  5. 1845
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Emerging hepatitis C virus and neuron-allied neuroviral intertwine and its therapeutic approaches
  6. 1846
    “…BACKGROUND: Sofosbuvir (SOF)- or simeprevir (SIM)-containing regimens are highly effective for treating chronic hepatitis C virus (HCV) infection. These regimens, however, are expensive. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study
  7. 1847
    “…BACKGROUND: Breakthrough direct-acting antivirals set a new standard in the management of hepatitis C virus (HCV) with regard to cure rates and improved tolerability; however, the health care system is challenged by the cost of these medications. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Overview of Comprehensive Hepatitis C Virus Medication Management in a State Medicaid Program
  8. 1848
    “…The use of specialty pharmacies by hepatitis C patients may improve persistence on the 3-drug hepatitis C regimens. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Specialty Pharmacy on Telaprevir-Containing 3-Drug Hepatitis C Regimen Persistence
  9. 1849
    “…This study aimed to elucidate the anti-hepatitis E virus (HEV) immunoglobulin G (IgG) prevalence and incidence of seroconversion and seroreversion as well as its risk factors and to analyze the clinical outcomes of HEV and hepatitis C virus (HCV) coinfected patients compared to those of HCV-monoinfected patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence, incidence, and outcomes of hepatitis E virus coinfection in patients with chronic hepatitis C
  10. 1850
    “…Background: About 400,000-500,000 people are infected with hepatitis C in Germany. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
  11. 1851
    “…The burden of hepatitis C virus (HCV) infection in Pakistan is amongst the highest in the world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence and risk factors for hepatitis C virus infection in an informal settlement in Karachi, Pakistan
  12. 1852
    “…SIMPLE SUMMARY: This case-control study investigates the associations between head and neck cancer (HNC), hepatitis B virus (HBV), and hepatitis C virus (HCV) infection. We included 5603 patients who had received a diagnosis of HNC as cases and 16,809 propensity score matching controls. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Associations of Head and Neck Cancer with Hepatitis B Virus and Hepatitis C Virus Infection
  13. 1853
    “…AIM OF THE STUDY: To investigate the role of the novel adipokines visfatin and vaspin in hepatitis C virus (HCV)-cirrhotic patients with and without hepatocellular carcinoma (HCC) and their association with tumour characteristics and liver dysfunction. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis
  14. 1854
    “…Screening for hepatitis C virus in community health center settings, which serve a disproportionate percentage of Latinos, is essential to eradicating hepatitis C virus infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Screening for Hepatitis C Among Community Health Center Patients by Ethnicity and Language Preference
  15. 1855
    “…Hepatitis C Virus (HCV), affecting millions of people worldwide, is the leading cause of liver disorder, cirrhosis, and hepatocellular carcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Computational medicinal chemistry applications to target Asian-prevalent strain of hepatitis C virus
  16. 1856
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Maternal hepatitis C virus infection and three adverse maternal outcomes in the United States
  17. 1857
    “…In addition, it is well-established that there is an association between Hepatitis C and ICP. This study’s objective was to describe the impact of having both Hepatitis C and ICP on maternal and obstetric outcomes compared to patients having either Hepatitis C or ICP. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts
  18. 1858
    “…KEY MESSAGES: • Target population does not feel susceptible to hepatitis c and has poor perception of severity. • It is necessary to improve communication through effective messages.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    General population knowledge, attitudes, and behaviors (KAB) on hepatitis c screening, Latium, Italy
  19. 1859
    “…In 2016, WHO set the goal of elimination of Hepatitis C Virus (HCV) by 2030. Globally, about 58 million people have chronic HCV, which causes cirrhosis, hepatocellular carcinoma and death (around 300000 in 2019), representing a heavy burden for public health. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C virus screening in Piemonte: an effective strategy to eliminate HCV chronic infections
  20. 1860
    “…Blood RNA-sequencing analysis for non-human RNA in 3984 participants from the COPDGene study identified 228 participants with evidence suggestive for hepatitis C virus (HCV) infection. We hypothesized that incidentally discovered HCV results could be effectively returned to COPDGene participants with attention to the identified concerns. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants
Herramientas de búsqueda: RSS